<i>In Vitro</i> Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of <i>Candida glabrata</i> , <i>Candida auris</i> , <i>Cryptococcus neoformans</i> , and <i>Pneumocystis</i> sppGeorge Tetz, Victor Tetz, Daria Vikina et al.|Antimicrobial Agents and Chemotherapy|2019Cited by 23
<i>In vitro</i> activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of <i>Candida glabrata, Candida auris, Cryptococcus neoformans</i> , and <i>Pneumocystis</i> sppGeorge Tetz, Victor Tetz, Margaret S. Collins et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 1